» Articles » PMID: 30973011

Reactive Oxygen Species (ROS)-Based Nanomedicine

Overview
Journal Chem Rev
Specialty Chemistry
Date 2019 Apr 12
PMID 30973011
Citations 396
Authors
Affiliations
Soon will be listed here.
Abstract

Reactive oxygen species (ROS) play an essential role in regulating various physiological functions of living organisms. The intrinsic biochemical properties of ROS, which underlie the mechanisms necessary for the growth, fitness, or aging of living organisms, have been driving researchers to take full advantage of these active chemical species for contributing to medical advances. Thanks to the remarkable advances in nanotechnology, great varieties of nanomaterials with unique ROS-regulating properties have been explored to guide the temporospatial dynamic behaviors of ROS in biological milieu, which contributes to the emergence of a new-generation therapeutic methodology, i.e., nanomaterial-guided in vivo ROS evolution for therapy. The interdependent relationship between ROS and their corresponding chemistry, biology, and nanotherapy leads us to propose the concept of "ROS science", which is believed to be an emerging scientific discipline that studies the chemical mechanisms, biological effects, and nanotherapeutic applications of ROS. In this review, state-of-art studies concerning recent progresses on ROS-based nanotherapies have been summarized in detail, with an emphasis on underlying material chemistry of nanomaterials by which ROS are generated or scavenged for improved therapeutic outcomes. Furthermore, key scientific issues in the evolution of ROS-based cross-disciplinary fields have also been discussed, aiming to unlock the innate powers of ROS for optimized therapeutic efficacies. We expect that our demonstration on this evolving field will be beneficial to the further development of ROS-based fundamental researches and clinical applications.

Citing Articles

High-Density Lipoprotein Biomimetic Inorganic-Organic Composite Nanosystem for Atherosclerosis Therapy.

Zhang Y, Liu D, Wang Y, Sun Q, Mei D, Wang X Polymers (Basel). 2025; 17(5).

PMID: 40076117 PMC: 11902788. DOI: 10.3390/polym17050625.


Binary peptide coacervates as an active model for biomolecular condensates.

Cao S, Zhou P, Shen G, Ivanov T, Yan X, Landfester K Nat Commun. 2025; 16(1):2407.

PMID: 40069227 PMC: 11897134. DOI: 10.1038/s41467-025-57772-z.


Nanomedicine: a cost-effective and powerful platform for managing neurodegenerative diseases.

Hassanzadeh-Khanmiri M, Moshari A, Kheradmand R, Haghgouei T, Homaei M, Charsouei S Metab Brain Dis. 2025; 40(3):142.

PMID: 40067468 DOI: 10.1007/s11011-025-01564-3.


Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment.

Han Q, Li J, Li Z, Aishajiang R, Yu D Mater Today Bio. 2025; 31:101601.

PMID: 40066079 PMC: 11891152. DOI: 10.1016/j.mtbio.2025.101601.


Macrophage-targeting Antisenescence nanomedicine enables in-Situ NO induction for Gaseous and antioxidative atherosclerosis intervention.

Peng Y, Feng W, Huang H, Chen Y, Yang S Bioact Mater. 2025; 48:294-312.

PMID: 40060144 PMC: 11889351. DOI: 10.1016/j.bioactmat.2025.02.025.